Market research

Periodontal Disease Treatment

Explore licenses

360iResearch introduction

Periodontal Disease Treatment: Executive Overview

Periodontal disease treatment addresses inflammatory conditions affecting the tissues that support teeth, ranging from gingivitis to advanced periodontitis. Management typically combines professional diagnosis, plaque and calculus removal, individualized oral-hygiene guidance, and, where necessary, nonsurgical or surgical periodontal therapy. Treatment decisions increasingly emphasize disease severity, patient risk factors, maintenance adherence, and coordination with broader health care.

Inside the research

Coverage at a glance

Selected branches from the published table of contents. Follow a chapter to explore its complete hierarchy.

  1. Chapter 7 Treatment Type

    • Non-Surgical Treatment
    • Surgical Treatment
    View chapter
  2. Chapter 8 Product Type

    • Devices
    • Medications
    • Regenerative Materials
    View chapter
  3. Chapter 9 Route Of Administration

    • Local
    • Systemic
    View chapter

Prevention, Precision, and Integrated Care Are Reshaping Treatment

The treatment landscape is shifting from episodic intervention toward prevention, risk-based monitoring, and long-term maintenance. Digital radiography, periodontal charting, intraoral imaging, and remote consultations can support earlier detection and more consistent follow-up, while minimally invasive approaches seek to preserve tissue and improve patient comfort. Greater recognition of links between periodontal inflammation and conditions such as diabetes and cardiovascular disease is also encouraging collaboration between dental and medical professionals, although these associations do not establish that periodontal treatment prevents systemic disease.

Artificial Intelligence Strengthens Detection and Clinical Workflow

Artificial intelligence is being applied to dental images, clinical records, and risk-assessment workflows to help identify bone loss, radiographic abnormalities, and patients who may need closer monitoring. Its practical value depends on representative training data, transparent validation, clinician oversight, and safeguards for privacy and informed consent. AI should support-not replace-periodontal examination, diagnosis, treatment planning, and communication with patients, particularly when findings are ambiguous or disease presentation is complex.

Regional Insights: Uneven Access Shapes Periodontal Care

North America generally combines advanced dental infrastructure with persistent affordability and insurance-access challenges. Europe benefits from established professional standards but varies in reimbursement, public coverage, and access across countries. Asia-Pacific contains highly developed dental systems alongside substantial unmet need in populous and rural communities. Latin America faces differences in public provision, household affordability, and specialist availability. In the Middle East, urban concentration of services and workforce distribution influence access, while Africa continues to experience major gaps in preventive dentistry, diagnosis, periodontal specialists, and essential supplies. Across all regions, tobacco use, diabetes, aging, oral-hygiene practices, and care-seeking behavior influence treatment demand and outcomes.

Group Insights: Economic and Institutional Differences Drive Priorities

ASEAN countries show varied dental-workforce capacity, urban–rural access, and public-health integration, making prevention and primary-care delivery important priorities. BRICS members face differing burdens of untreated oral disease, income inequality, and specialist distribution, with scalable basic periodontal services often central to policy discussions. European Union systems differ in reimbursement and national prevention strategies despite shared regulatory frameworks. G7 countries generally have stronger clinical capacity but still confront aging populations, inequalities, and affordability barriers. GCC states have invested in modern health infrastructure, while access and workforce localization remain relevant considerations. NATO members span diverse health systems, so alliance membership does not imply uniform periodontal-care provision.

Country Insights: Distinct Health Systems Require Tailored Delivery

Australia and Canada must address geographic dispersion, Indigenous and rural access gaps, and preventive-care affordability. Brazil, Mexico, India, and Russia face substantial variation between metropolitan and underserved areas, requiring stronger primary-care referral pathways and workforce distribution. China is expanding oral-health capacity while managing large population needs and uneven regional access. France, Germany, Italy, Spain, and the United Kingdom have established dental professions but differ in public coverage, reimbursement, and integration with medical care. Japan and South Korea combine advanced clinical capabilities with aging-related maintenance needs. In the United States, access, insurance design, socioeconomic disparities, and care coordination remain central implementation issues.

Actions for Leaders: Make Periodontal Care Earlier, More Accessible, and Measurable

Industry leaders should prioritize risk-based recall systems, standardized periodontal assessment, and clear pathways from primary dental care to specialists. Expand prevention through community programs, tobacco-cessation support, diabetes-care coordination, and patient education designed for health literacy. Use digital imaging and AI only with clinical validation, bias monitoring, cybersecurity controls, and documented human review. Improve adherence by communicating treatment benefits and maintenance requirements clearly, offering flexible scheduling, and measuring outcomes such as bleeding reduction, pocket-depth control, tooth retention, and follow-up continuity. Partnerships with public-health systems can help extend services to rural, older, and economically disadvantaged populations.

Research Methodology: Evidence-Based Review of Treatment and Care Delivery

This executive summary should be developed through a structured review of peer-reviewed periodontal research, clinical practice guidelines, government and intergovernmental oral-health reports, health-system publications, and validated technology studies. Evidence should be screened for relevance, methodological quality, geographic coverage, and recency, with clinical claims separated from associations and expert commentary. Regional, group, and country comparisons should reflect documented differences in disease burden, workforce, financing, access, prevention, and treatment practices. Technology findings should be assessed for validation, generalizability, safety, privacy, and clinician oversight. No unsupported estimates, forecasts, market shares, or company-specific claims are used.

Conclusion: Sustainable Outcomes Depend on Prevention and Continuity

Periodontal disease treatment is moving toward earlier identification, conservative intervention, digitally supported monitoring, and closer integration with primary and medical care. The greatest practical gains will come from combining clinically sound therapy with prevention, maintenance adherence, equitable access, and reliable referral systems. AI can improve consistency and workflow when governed responsibly, but workforce expertise and patient-centered care remain essential. Leaders who measure outcomes across diverse populations and address structural barriers will be better positioned to improve long-term periodontal health.

Research report

Table of contents

  1. 1.Preface
    1. 1.1Objectives of the Study
    2. 1.2Market Definition
    3. 1.3Market Segmentation & Coverage
    4. 1.4Years Considered for the Study
    5. 1.5Currency Considered for the Study
    6. 1.6Language Considered for the Study
    7. 1.7Key Stakeholders
  2. 2.Research Methodology
    1. 2.1Introduction
    2. 2.2Research Design
      1. 2.2.1Primary Research
      2. 2.2.2Secondary Research
    3. 2.3Research Framework
      1. 2.3.1Qualitative Analysis
      2. 2.3.2Quantitative Analysis
    4. 2.4Market Size Estimation
      1. 2.4.1Top-Down Approach
      2. 2.4.2Bottom-Up Approach
    5. 2.5Data Triangulation
    6. 2.6Research Outcomes
    7. 2.7Research Assumptions
    8. 2.8Research Limitations
  3. 3.Executive Summary
    1. 3.1Introduction
    2. 3.2CXO Perspective
    3. 3.3New Revenue Opportunities
    4. 3.4Next-Generation Business Models
    5. 3.5Industry Roadmap
  4. 4.Market Overview
    1. 4.1Introduction
    2. 4.2Industry Ecosystem & Value Chain Analysis
      1. 4.2.1Supply-Side Analysis
      2. 4.2.2Demand-Side Analysis
      3. 4.2.3Stakeholder Analysis
    3. 4.3Market Dynamics
      1. 4.3.1Key Drivers
      2. 4.3.2Key Restraints
      3. 4.3.3Key Opportunities
      4. 4.3.4Key Challenges
    4. 4.4Porter’s Five Forces Analysis
    5. 4.5PESTLE Analysis
    6. 4.6Market Outlook
      1. 4.6.1Near-Term Market Outlook (0–2 Years)
      2. 4.6.2Medium-Term Market Outlook (3–5 Years)
      3. 4.6.3Long-Term Market Outlook (5–10 Years)
    7. 4.7Go-to-Market Strategy
  5. 5.Market Insights
    1. 5.1Consumer Insights & End-User Perspective
    2. 5.2Consumer Experience Benchmarking
    3. 5.3Opportunity Mapping
    4. 5.4Distribution Channel Analysis
    5. 5.5Pricing Trend Analysis
    6. 5.6Regulatory Compliance & Standards Framework
    7. 5.7ESG & Sustainability Analysis
    8. 5.8Disruption & Risk Scenarios
    9. 5.9Return on Investment & Cost-Benefit Analysis
  6. 6.Cumulative Impact of Artificial Intelligence 2026
  7. 7.Periodontal Disease Treatment Market, by Treatment Type
    1. 7.1Introduction
    2. 7.2Non-Surgical Treatment
      1. 7.2.1Laser Therapy
      2. 7.2.2Scaling & Root Planing
    3. 7.3Surgical Treatment
      1. 7.3.1Bone Grafting
      2. 7.3.2Flap Surgery
      3. 7.3.3Guided Tissue Regeneration
  8. 8.Periodontal Disease Treatment Market, by Product Type
    1. 8.1Introduction
    2. 8.2Devices
      1. 8.2.1Laser Devices
      2. 8.2.2Scalers & Cutters
      3. 8.2.3Ultrasonic Devices
    3. 8.3Medications
      1. 8.3.1Antibiotics
      2. 8.3.2Antiseptic Chips
      3. 8.3.3Non-steroidal Anti-inflammatory Drugs
    4. 8.4Regenerative Materials
      1. 8.4.1Bone Fillers
      2. 8.4.2Collagen Membranes
  9. 9.Periodontal Disease Treatment Market, by Route Of Administration
    1. 9.1Introduction
    2. 9.2Local
    3. 9.3Systemic
  10. 10.Periodontal Disease Treatment Market, by Disease Type
    1. 10.1Introduction
    2. 10.2Aggressive Periodontitis
    3. 10.3Chronic Periodontitis
    4. 10.4Gingivitis
    5. 10.5Necrotizing Periodontal
  11. 11.Periodontal Disease Treatment Market, by Patient Type
    1. 11.1Introduction
    2. 11.2Adults
    3. 11.3Geriatric
    4. 11.4Pediatric
  12. 12.Periodontal Disease Treatment Market, by End-User
    1. 12.1Introduction
    2. 12.2Academic & Research Institutes
    3. 12.3Ambulatory Surgical Centers
    4. 12.4Dental Clinics
    5. 12.5Homecare Settings
    6. 12.6Hospitals
  13. 13.Periodontal Disease Treatment Market, by Distribution Channel
    1. 13.1Introduction
    2. 13.2Offline
    3. 13.3Online
  14. 14.Periodontal Disease Treatment Market, by Region
    1. 14.1Introduction
    2. 14.2Asia-Pacific
    3. 14.3North America
    4. 14.4Latin America
    5. 14.5Europe
    6. 14.6Middle East
    7. 14.7Africa
  15. 15.Periodontal Disease Treatment Market, by Group
    1. 15.1Introduction
    2. 15.2ASEAN
    3. 15.3GCC
    4. 15.4European Union
    5. 15.5BRICS
    6. 15.6G7
    7. 15.7NATO
  16. 16.Periodontal Disease Treatment Market, by Country
    1. 16.1Introduction
    2. 16.2United States
    3. 16.3Canada
    4. 16.4Mexico
    5. 16.5Brazil
    6. 16.6United Kingdom
    7. 16.7Germany
    8. 16.8France
    9. 16.9Russia
    10. 16.10Italy
    11. 16.11Spain
    12. 16.12China
    13. 16.13India
    14. 16.14Japan
    15. 16.15Australia
    16. 16.16South Korea
  17. 17.Competitive Landscape
    1. 17.1Market Share Analysis, 2025
    2. 17.2Market Concentration Analysis, 2025
      1. 17.2.1Concentration Ratio (CR)
      2. 17.2.2Herfindahl Hirschman Index (HHI)
    3. 17.3Recent Developments & Impact Analysis, 2025
    4. 17.4Product Portfolio Analysis, 2025
    5. 17.5Benchmarking Analysis, 2025
  18. 18.Company Profiles
    1. 18.13M Company
    2. 18.2ACTEON Group
    3. 18.3Bausch Health Companies Inc.
    4. 18.4Becton, Dickinson and Company
    5. 18.5BioHorizons, Inc.
    6. 18.6Colgate-Palmolive Company
    7. 18.7Convergent Dental, Inc.
    8. 18.8Den-Mat Holdings, LLC
    9. 18.9Dentsply Sirona Inc.
    10. 18.10GC Corporation
    11. 18.11Geistlich Pharma AG
    12. 18.12GlaxoSmithKline plc
    13. 18.13Haleon group
    14. 18.14Henry Schein, Inc.
    15. 18.15Ivoclar Vivadent AG
    16. 18.16Johnson & Johnson
    17. 18.17Kuraray Noritake Dental Inc.
    18. 18.18Lion Corporation
    19. 18.19Mectron S.p.A.
    20. 18.20Patterson Companies, Inc.
    21. 18.21Pfizer Inc.
    22. 18.22Procter & Gamble Company
    23. 18.23Septodont Holding SAS
    24. 18.24Shofu Dental Corporation
    25. 18.25Straumann Group
    26. 18.26Sunstar Suisse SA
    27. 18.27TePe Oral Health Care, Inc.
    28. 18.28Ultradent Products, Inc.
    29. 18.29VOCO GmbH
    30. 18.30Water Pik, Inc.
    31. 18.31Zimmer Biomet Dental
  19. 19.Key Experts

Loading the sample request form…